Monday, July 13, 2020

Trend Micro and Girls in Tech Partner to Help Close the Gender Gap in the Technology Industry


Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global leader in cybersecurity solutions, today announced a new initiative in its long-running effort to close the diversity and talent gap in the technology industry. The company will extend its partnership with Girls in Tech, a global non-profit bringing the world together through education and experiences. Together, the two organizations will address the worldwide skills shortage in cybersecurity by helping to develop a large talent pool of women eager to get their start in the industry.

Although there is a global shortfall of more than four million cybersecurity professionals today, just a quarter (24%) of current roles are estimated to be taken by women. Both organizations, with global reach, are passionate about connecting with more women and gender-diverse talent and helping find them opportunities to advance their careers and secure the future. Girls in Tech, with 60,000 global members, has been dedicated to raising awareness of this skills gap and to overcome the divide for more than ten years and Trend Micro runs global education programs with a focus on helping women develop new skills to fill the open jobs.

“I’ve always been passionate about and dedicated to encouraging greater gender diversity in the industry. It’s why at Trend Micro we’re committed to supporting equal opportunities in the workplace and in 2018 launched our Close the Gap initiative,” said Eva Chen, co-founder and CEO of Trend Micro. “I’m delighted to be teaming with Girls in Tech to further advance our efforts. Especially in light of recent events, I believe we must celebrate and encourage diversity at every turn today. It’s what makes us human.”

As part of this expanded partnership with Girls in Tech, Trend Micro will develop a new Cybersecurity Fundamentals course for the non-profit. Instead of choosing a course that already exists within the program, Trend Micro has called on its world-class security team to build a custom course for Girls in Tech specific to today’s market need. The course, a blend of e-learning, online instructor-led classes and a hands-on lab via Trend Micro Product Cloud, will cover cybersecurity essentials, network security threats, an introduction to malware analysis, and much more.

“Girls in Tech shares with Trend Micro a unified vision for a future in which women are provided the same opportunities to pursue professions in technology as their male counterparts,” said Adriana Gascoigne, founder and CEO of Girls in Tech. “We look forward to continuing our partnership with Trend Micro to positively impact the technology landscape for women today and generations to come.”

Trend Micro and Girls in Tech first worked together on the Close the Gap program at AWS re:Invent 2018 where they brought managing directors from 30 global Girls in Tech chapters together to brainstorm diversity ideas and programs with industry executives.

Registration for the new Cybersecurity Fundamentals course is now open. The virtual course will run from Aug. 31 to Sept. 25 and last four hours per week.

Mamaearth Starts a ‘Goodness Revolution’ with the Promise of #GoodnessInside


In its latest brand campaign, Mamaearth, a toxin-free personal care startup, announced its brand purpose as “Goodness Inside”. 

Goodness starts with the small things that each one of us can do every day! It resides in the little choices we can make in our daily lives. Mamaearth’s latest video brings forth this idea of ‘Goodness is a Choice’ to its consumers. It is a digital and social media led campaign with the key message that goodness isn’t a superpower or a special gift. It is simply a choice that you make every day, just like the choices that Mamaearth makes in its products and as a brand.

In 2016, Mamaearth came into being with the same philosophy. The brand has always chosen goodness in their products by using only the best of nature and not using any harmful chemicals or toxins in their products. Their philosophy of being animal cruelty free (PETA certified) and plastic positive, further adds to the goodness in the brand. Mamaearth recognises that millennial consumers have the same belief system. 

Mamaearth is Asia’s first brand with products that have Madesafe certification. It offers 100% toxin-free baby care, skincare, and hair care products, made from the best of nature. Started with six products in the baby care range, Mamaearth has now diversified into skin and hair care products for men and women across 100+ SKUs. Their growth story is fuelled by the "Generation good" – millenials who identify with the brand purpose.

“Millennials want to do good and steer their families into a better tomorrow. That’s why we call this generation as ‘Generation Good’.  At Mamaearth, we share the same values and moral compass as Gen Good. Our new tagline ‘Goodness Inside’ is a promise that we will do what is right for our consumers and for Mother Earth by staying loyal to our product roots of toxin free purity and natural goodness.” Said Ghazal Alagh, Co-Founder and Chief Mum at MamaEarth.

The brand purpose of Goodness Inside comes from what Mamaearth has stood for all along since its inception. It is also an environmentally conscious brand working towards the conservation of Mother Earth for future generations by recycling more plastic than they use. Their toxin-free products promise purity and natural goodness which is better not just for people but for the planet as well.

Commenting on the ‘Goodness Inside’ campaign, VS Kannan Sitaram, Venture Partner at Fireside Ventures said “We at Fireside firmly believe that great brands serve a larger purpose beyond delivering product benefits. Mamaearth is an outstanding example of a brand that lives its purpose in an admirable manner. Its values resonate strongly with its consumers and creates a loyal, growing community of consumers. With this firm anchoring, Mamaearth is set to grow multifold."

In its 4 years of existence, Mamaearth has stood by the promise of honesty and goodness in everything they do. In the wake of the COVID-19 pandemic, Mamaearth decided not to profit from the situation by selling sanitizers. Instead, they distributed 50,000 sanitizers to people in need through 2500+ Goodness Ambassadors across the country. Recently, they’ve also distributed cotton reusable face masks with smiles printed on them, through these Goodness Ambassadors.

Lil’Goodness Introduces Immunity-Based Nutrition Filled with Vitamins and Minerals at their Doorsteps


Lil’Goodness, a Bengaluru-based kids food and nutrition start-up has been constantly innovating during this pandemic to positively influence the eating habits of the present and future generation through tasty, nutritious food options. Based on feedback received from parents, they have now introduced ‘Hearty’ – an initiative to provide immunity based nutritious meals filled with vitamins and minerals for those with medical needs across age groups at the convenience of their doorsteps.

‘Hearty’ from Lil’Goodness will offer some delightful ready-to-eat and easy-to-digest meal options from traditional Indian cuisines to international cuisines at a desired time-slot and can be ordered through whatsapp or text/telecall. The offering includes a free session with a nutritionist to understand medical conditions. Curated by nutrition experts, the meals are designed based inputs from nutritional experts and are customised for age specific carbs, proteins and healthy fats. Each meal also follows the Plate Method way of eating that ensures right portion sizes and high fibre intake that provides all micronutrients and prevents excess weight gain along with common old age problems like indigestion, diabetes, hypertension and cardiac issues, specifically critical during the times of COVID-19.

Prepared in safe and hygienic facilities, ‘Hearty’ is prepared from the best ingredients, are nutritionally balanced and freshly prepared for consumption. The company has a 9 point safety check in place that includes daily temperature checks of all staff, sanitization of facility and deep cleaning of vegetables along with UVC sterilization and contactless delivery in the light of the ongoing COVID-19 pandemic.

Commenting on the launch of this new initiative, Harshavardhan, CEO & Co-Founder Lil’Goodness said, “In the present pandemic situation, lower immunity levels and co-morbidities put the population with medical needs at a higher risk for coronavirus disease. There are also strict restrictions on their mobility. In our endeavour to positively influence lives, we realised that there was an urgent need to provide a convenient and contactless doorstep delivery of nutritious meals freshly prepared for those who have specific medical conditions such as diabetes, hypertension, cancer etc. Encouraged by the success of our test marketing initiative with a group of 10 families where we received positive feedback and repeat orders, we have now decided to launch this service across the city.

Pariksha Rao, Chief Nutritionist & Co-founder, Lil’Goodness said, “Without doubt, boosting immunity is the utmost priority for most of us. ‘Hearty’ aims at providing all the right nutrition for the immunity and health of those with chronic conditions. Our NutriWiz consulting platform will help us understand the specific needs of these consumers, based on which the menu is tweaked to suit their needs. Consumption of nutritious foods rich in micronutrients including antioxidant vitamins and minerals and fiber, comfortable level of physical activity will enable the elderly to live active and meaningful healthy lives.”

About Lil’Goodness:

Lil’Goodness and sCoolMeal is a Bangalore based scientific food and nutrition enterprise with a vision to positively influence the eating habits of the future generation through tasty, nutritious food options. With special focus on kids, the company is aiming at empowering millennial moms with a unique combination of ‘goodness’ filled choices for their lil’ ones.

The company, led by IIM Calcutta alumnus, Harshavardhan & nutrition expert Pariksha Rao, with the vision of tr the eating habits among children through a comprehensive ecosystem of fresh and packaged meal options integrated with technology to create awareness of eating right amongst kids at an early age.

Set up in 2018, the company after investing more than 1000 hours in on-ground research talking to mothers and experimenting with recipes, the kids’ food and nutrition went live in July 2019. In September 2019, Lil’Goodness acquired sCoolMeal –a foodtech startup that provided services related to catering and serving, nutritious and wholesome food, including sourcing, preparation and delivery of a balanced meal to school children.

Saturday, July 11, 2020

It’s Time Now to Look Ahead at Life Confidently with Corona Kaavach by HDFC ERGO


HDFC ERGO, the country’s third largest non-life insurance provider in the private sector, announced the launch of ‘Corona Kavach’ policy. This new indemnity health policy will offer cover against medical expenses incurred due to hospitalization of individuals seeking treatment for COVID-19, on positive diagnosis for the virus in a government authorized diagnostic centre. In addition, the policy will also cover expenses incurred on treatment of co-morbidity along with the treatment for COVID-19.

The current pandemic is a grave threat to the health of individuals, whilst also affecting their financial well-being due to the high cost of COVID-19 treatment. But, we must slowly gather the pace to ‘Look Ahead’and move towards the new normal, with confidence. The ‘Corona Kavach’policy indemnifies policyholders for medical expenses on hospitalization for the treatment of the virus and includes the expense incurred on treating co-morbidity along with COVID-19. The policy will also cover road ambulance expenses, in case the service is opted for the purpose of hospitalization due to COVID-19. Home Care Expenses benefit (upto a period of 14 days) will also be covered in the policy for those seeking treatment within the comfort of their own homes, on the advice of a medical practitioner. Additionally, expenses incurred for inpatient care treatment taken under Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homeopathy (AYUSH) systems of medicines will also be covered under the policy. Policyholders will also be liable for Hospital daily cash, which will be 0.5% of sum insured per day for a maximum upto 15 days, during a policy period.

Commenting on the launch of the new product, Mr. Ritesh Kumar, MD & CEO, HDFC ERGO General Insurance Company Ltd., “COVID-19 has brought life to a standstill with many feeling the financial pinch. In such unprecedented times, Corona Kavach by HDFC ERGO will provide customers with the much needed financial respite giving them the confidence to ‘Look Ahead’ in life. We are fully committed in this battle against COVID-19 and will provide our customers with the much required ammunition like access to a wide network of over 11,000 cashless hospitals, swift & hassle-free claim settlements, several services available digitally on HDFC ERGO’s my:health App; all of which will be available to them with our policy.”

The Corona Kavach policy by HDFC ERGO will enable customers to experience superior customer service whereby they can reach out to the Company through various digital platforms which are easily accessible. HDFC ERGO has a robust digital service architecture that has enabled the Company to put in place processes, which are largely paperless. Customers can register their request for filing a claim, policy renewals, and changes in the existing policy, among others through various means like the web portal, mobile apps, IVR, chatbotsand email bots from the convenience of their homes. HDFC ERGO’s settlement of pre-authorized cashless claims withinan average of 14 minuteshas further enhanced customer satisfaction and delight.

As an added advantage, existing indemnity health policyholders can avail a 25% discount and our Health Warriors, i.e. the Health care professionals, especially will be offered an additional 5% discount on purchase of this policy. The policy is available for a minimum sum insured of INR 50,000/- up to a maximum of INR 5,00,000/-. Customers may logon to the Company website www.hdfcergo.com or reach out to HDFC ERGO representatives for more details or purchase the Corona Kavach policy.

About HDFC ERGO:

HDFC ERGO General Insurance Company Ltd. is a 51:49 joint venture between the Housing Development Finance Corporation Ltd (HDFC); India’s premier Housing Finance Institution and ERGO International AG; the primary insurance entity of the Munich Re Group of Germany. HDFC ERGO, the third largest General Insurance provider in the private sector, offers the complete range of general insurance products including Motor, Health, Home, Agriculture, Travel, Credit, Cyber and Personal Accident in the retail space and Property, Marine, Engineering, Marine Cargo, Group Health and Liability Insurance in the corporate space.

Over the last few years, HDFC ERGO has constantly endeavoured to not just align itself to the evolving market needs, but instead be a pioneer in terms of its offerings. Having its ears to the ground has helped the Company create a stream of highly targeted new products and AI-based tools and technology. Be it unique insurance products, integrated customer service models, top-in-class claim process or a host of technologically innovative solutions.

With a wide distribution network and a 24x7 support team, the Company has been offering seamless customer service and innovative products to its customers.For more information on HDFC ERGO and the products and services offered by the Company.

Emirates Announces Repatriation Flights to Five Indian Cities Between July 12-26, 2020



Emirates will be operating special repatriation flights to five Indian cities between 12 and 26 July to assist stranded Indians get home and for residents of UAE currently in India to return to the UAE.

The flights will be operated to Bengaluru, Delhi, Kochi, Mumbai and Thiruvananthapuram between 12 and 26 July 2020 offering the following flight frequencies

Bengaluru: twice daily flights
Delhi: twice daily flights
Kochi: twice daily flights
Mumbai: thrice daily flights
Thiruvananthapuram: once daily flights

The flights to Bengaluru and Mumbai are subject to state government approval.

Flights can be booked on emirates.com, through travel agents, Emirates’ sales offices and contact centre. Passengers must meet all the entry requirements of the destination to be allowed to board the flights.

Flights from Dubai to India
Only Indian citizens stranded in the UAE will be allowed to fly from Dubai to the five Indian destinations.

Flights from India to Dubai
These flights will be available for UAE nationals and residents with prior entry approval from the General Directorate of Residency and Foreign Affairs (GDFRA) for residents of Dubai and ICA approval for residents of other emirates of the UAE.

All passengers travelling from airports in India to Dubai are also required to carry a negative Reverse Transcription Polymerase Chain Reaction (RT-PCR) certificate issued by a laboratory authorised by the government of India to be accepted on the flight. Certificates must be issued no more than 96 hours before departure.

More information for returning UAE residents can be found at https://www.emirates.com/ae/english/help/flying-to-and-from-dubai/

Health and Safety First
Emirates has implemented a comprehensive set of measures at every step of the customer journey to ensure the safety of its customers and employees on the ground and in the air. Emirates has modified its services onboard these flights in line with requirements from the authorities. Visit www.emirates.com/wherewefly for more information on the products and services onboard each flight.

Premium customers travelling from Dubai can now also enjoy Emirates’ Chauffeur Drive service and relax in its Lounge facility at Dubai International airport, with the restart of these signature services after a full health and safety review.

Emirates continues to offer customers a wide range of travel options. The airline’s network will encompass 58 cities by mid-August covering destinations across six continents.

Pankajakasthuri Announces Promising Interim Results for ZingiVir–H Among COVID-19 Patients


Pankajakasthuri Herbals India Private Limited (PKHIL) today announced promising interim clinical trial results for ZingiVir-H among patients suffering from COVID-19. Developed by Dr. J. Hareendran Nair, Founder of Pankajakasthuri Herbal Research Foundation, ZingiVir-H is a herbo-mineral drug made of a blend of seven ingredients. With the announcement, the company hopes to reiterate the 
tremendous potential of Ayurveda as a cost-effective and scalable solution to critical health conditions such as COVID-19.

Dr. J. Hareendran Nair, Founder and Managing Director, PKHIL, said, “Ayurveda has a long and storied tradition of helping treat a wide range of conditions, from everyday allergies to more complex ones such as autoimmune diseases. During such unprecedented times as now, where our immunity is critical to fighting a disease that has become a global pandemic, we believe that Ayurveda has the power to help develop an effective, cost-efficient and scalable treatment.”

Clinical trials of ZingiVir-H, Pankajakasthuri’s new drug, are underway among 112 patients as an adjunct therapy for the pandemic as well as among 135 additional patients as a stand-alone treatment in a double-blind study. The trials are progressing in 96 of the patients undergoing adjunct therapy. Out of these, the results of 42 patients are being published as an interim report. Among the 42 patients, 22 were treated with ZingiVir-H and 20 were treated with a placebo. It was found that all the 22 patients treated with ZingiVir-H were discharged on the fourth day after real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR). The remaining 20 patients in the control group who received placeboes continued to be COVID-19+ve for 5 to 11 days.

“The results so far have been very positive and the trial is continuing,” said Dr. Nair. “We are equipped to provide the tablet as a treatment for COVID-19 across India and will collaborate with government bodies to ensure effective and quick distribution once the drug is approved. After this, we would also like to extend the treatment to regulators around the world for their respective countries. It is especially important to know that the use of the drug as a prophylactic treatment means that ZingiVir-H can help prevent the spread of COVID-19 and thereby prevent community transmission.”

ZingiVir-H tablets had obtained the Drugs License of the Government of Kerala and underwent cytotoxicity tests on human cells at the Rajiv Gandhi Center for Biotechnology and CSIR-NIIST at Thiruvananthapuram. After the animal studies were proved to be harmless, the clinical trial registration was obtained from the Clinical Trial Registry of India (CTRI). Thereafter, the drug was placed in Randomized Single Blind Placebo Controlled Multi-Center Clinical Trial as per World Health Organization (WHO)'s ICH-GCP standards at various medical colleges with approvals from respective ethical committees.

ZingiVir-H's clinical trial is being conducted similar to the testing protocols in modern medicine. The results will be published after completion of the clinical trials and blood tests, including CRP, ESR, Interleukin, IgG and IgM, have proven the defensive functionality/efficacy of ZingiVir-H.

The interim clinical test results have been evaluated by a 5-member independent peer data monitoring committee (DMC). These included:

* The Chairman of the committee, Dr. V. Raman Kutty, Eminent Epidemiologist and data science expert, Research Director, Amala Cancer Research Centre, Thrissur. He is also a Former Emeritus Professor of Sree Chitra Tirunal Institute for Medical Sciences and Technology and Honorary Chairman, Health Action by People.

* Dr. K. P. Poulose, Former Professor, Kottayam Medical College & George Washington University, USA and Chief Physician, SUT Hospitals, Thiruvananthapuram;

* Dr. K. G. Raveendran, Retd. Medical Director, The Arya Vaidya Pharmacy, Coimbatore;

* Dr. V. S. SUGUNAN, Former Scientist C and Group Leader, Viral Hepatitis Laboratory, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram; and

* Dr. Asha Kamath, Associate Director, PSPH, Professor & Head, Department of Data Science, Manipal Academy of Higher Education.

Dr. Hareendran Nair also thanked the R&D head of Pankajakasthuri Dr. Shan Sashidharan and the Clinical Trial Coordinator Dr. K. P. Srinivasakumar, Head, Clinical Operations, Institute of Biology and Clinical Research, India, and others associated with it.

After the peer review from the DMC, the test results have been submitted for the approval by the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH).

St. John’s Health Centre Opens New Centre at Brigade Meadows on Kanakapura Road


St. John's Health Centre is pleased to announce the commencement of a public health centre at  60-acre integrated development, Brigade Meadows on Kanakapura Road, adjacent to the Art of Living in South Bengaluru.

This not for profit initiative is a joint effort of Brigade Foundation and the highly reputed St. John’s Medical College and Hospital. The St. John’s Health Centre would cater to the neighbourhood and will eventually become a full-fledged hospital. The Health Center was inaugurated by His Grace, Most Rev. Dr. Peter Machado, the Archbishop of Bangalore in the presence of Rev. Dr. Paul Parathazham, Director, St. John’s Medical College and Hospital, Mr. M R Jaishankar, CMD, Brigade Group and a limited audience, due to the current regulations.

The St. John’s Health Centre has commenced its services from June 25, 2020 and will cater to all the primary health care needs of a family and provide referral services where needed. The Centre will provide outpatient services, basic laboratory facility, radiology, ultrasound and a pharmacy. This will include general medicine, paediatrics, obstetrics, gynaecology and family medicine. There will also be skin, eye, dental, general surgery and ENT services. A basic first aid/casualty service will be available around the clock

According to His Grace, Most Rev. Dr. Peter Machado, the Archbishop of Bangalore, “ This not-for-profit initiative is a collaborative effort of two Charitable Societies, the CBCI Society for Medical Education, which owns the St. John’s Medical College and Hospital, and Brigade Foundation. The health centre is well aligned with the original mission of St. John’s to make quality healthcare accessible and affordable especially to the underprivileged and the underserved.”

Total Pageviews